The Treatment of Diabetic Retinopathy
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 110 | Views: 458 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Medicine Science | Albania | Volume 4 Issue 8, August 2015 | Popularity: 6.3 / 10


     

The Treatment of Diabetic Retinopathy

Orgeta Dervishi, Vilma Mema


Abstract: Retinopathy is a major cause of morbidity in patients with type 1 and 2 diabetes. The incidence of blindness, for example, is much higher in patients with diabetes than in the general population. This is a systematic review of reports, articles and guidelines published in web regarding the treatment and management of diabetic retinopathy. The indications and timing for photocoagulation and vitrectomy achieved consensus across all guidelines. Intraocular steroids and anti-VEGF agents have consistently generated interest as having the greatest potential in treatment of diabetic macular edema and proliferative disease. Recommendations for the use of intraocular corticosteroids in treatment of DME achieved consensus across the guidelines. All studies acknowledged that intravitreal corticosteroids including triamcinolone (IVTA) was widely used in managing DME that was refractory to focal/grid laser.


Keywords: diabetic retinopathy, treatment, medication, guidelines


Edition: Volume 4 Issue 8, August 2015


Pages: 1909 - 1912



Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Orgeta Dervishi, Vilma Mema, "The Treatment of Diabetic Retinopathy", International Journal of Science and Research (IJSR), Volume 4 Issue 8, August 2015, pp. 1909-1912, https://www.ijsr.net/getabstract.php?paperid=SUB157755, DOI: https://www.doi.org/10.21275/SUB157755

Top